Physiopathology of intrauterine growth retardation: From classic data to metabolomics

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue SUPPL. 5, 2012, Pages 13-18

  Dessì, Angelica ^a   Ottonello, Giovanni ^a   Fanos, Vassilios ^a,b  

^a DEPARTMENT OF RADIOLOGY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Biomarkers; Fetal nutrition; IUGR; Metabolomics; Perinatal programming

Indexed keywords

ENDOTHELIN 1; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN S100B;

ADULTHOOD; CHRONIC DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; DYSLIPIDEMIA; EPIGENETICS; FETUS GROWTH; GENOTYPE; HUMAN; HYPERTENSION; INBORN ERROR OF METABOLISM; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL NUTRITION; METABOLIC SYNDROME X; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RESTRICTION; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ENDOTHELIN-1; EPIGENOMICS; FEMALE; FETAL GROWTH RETARDATION; FETAL NUTRITION DISORDERS; GENOTYPE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LEPTIN; METABOLOMICS; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84866992377     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.714639     Document Type: Review

References (64)

1. Diderholm B. Perinatal energy metabolism with reference to IUGR & SGA: studies in pregnant women & newborn infants. Indian J Med Res 2009;130:612-617.
2. Committee on Practice Bulletins Gynecology, American College of Obstetricians and Gynecologists, Washington, DC 20090-6920, USA. Intrauterine growth restriction. Clinical management guidelines for obstetrician- gynecologists. Int J Gynaecol Obstet 2001;72:85-96.
3. McCowan LM, Roberts CT, Dekker GA, Taylor RS, Chan EH, Kenny LC, Baker PN, et al.; SCOPE consortium. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG 2010;117:1599-1607.
4. King JC. Physiology of pregnancy and nutrient metabolism. Am J Clin Nutr 2000;7:1218-1225.
5. Nicoletto SF, Rinaldi A. In the womb's shadow. The theory of prenatal programming as the fetal origin of various adult diseases is increasingly supported by a wealth of evidence. EMBO Rep 2011;12:30-34.
6. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986;1:1077-1081.
7. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-580.
8. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann N Y Acad Sci 2010;1205:99-105.
9. Woodall SM, Johnston BM, Breier BH, Gluckman PD. Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of ofspring. Pediatr Res 1996;40:438-443.
10. Fernandez-Twinn DS, Ozanne SE. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006;88:234-243.
11. Desai M, Babu J, Ross MG. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol 2007;293:R2306-R2314.
12. Bispham J, Gardner DS, Gnanalingham MG, Stephenson T, Symonds ME, Budge H. Maternal nutritional programming of fetal adipose tissue development: diferential efects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferator-activated and prolactin receptors. Endocrinology 2005;146:3943-3949.
13. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker O P. Glucose tolerance in adults afer prenatal exposure to famine. Lancet 1998;351:173-177.
14. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991;303:1019-1022.
15. Hales CN, Barker DJ. The thrify phenotype hypothesis. Br Med Bull 2001;60:5-20.
16. Eriksson JG, Forsén T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999;318:427-431.
17. Morrison JL, Dufeld JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol 2010;25:669-677.
18. Claris O, Beltrand J, Levy-Marchal C. Consequences of intrauterine growth and early neonatal catch-up growth. Semin Perinatol 2010;34:207-210.
19. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004;56:311-317.
20. Gluckman PD, Hanson MA, Morton SM, Pinal CS. Life-long echoes-a critical analysis of the developmental origins of adult disease model. Biol Neonate 2005;87:127-139.
21. Gluckman PD, Cutfeld W, Hofman P, Hanson MA. The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum Dev 2005;81:51-59.
22. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 1999;42:139-145.
23. Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G. Low birthweight and metabolic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus. Diabet Med 2000;17:365-370.
24. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089-1093.
25. Sebert S, Sharkey D, Budge H, Symonds ME. The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr 2011;94:1953S-1958S.
26. Fuller NJ, Bates CJ, Cole TJ, Lucas A. Plasma folate levels in preterm infants, with and without a 1 mg daily folate supplement. Eur J Pediatr 1992;151:48-50.
27. Liotto N, Miozzo M, Giannì ML, Taroni F, Morlacchi L, Piemontese P, Roggero P, Mosca F. Early nutrition: the role of genetics and epigenetics. Pediatr Med Chir 2009;31:65-71.
28. Hulsey TC, Neal D, Bondo SC, Hulsey T, Newman R. Maternal prepregnant body mass index and weight gain related to low birth weight in South Carolina. South Med J 2005;98:411-415.
29. Smith GC, Konycheva G, Dziadek MA, Ravelich SR, Patel S, Reddy S, Breier BH, et al. Pre-and postnatal methyl defciency in the rat diferentially alters glucose homeostasis. J Nutrigenet Nutrigenomics 2011;4:175-191.
30. Liguori A, Puglianiello A, Germani D, Deodati A, Peschiaroli E, Cianfarani S. Epigenetic changes predisposing to type 2 diabetes in intrauterine growth retardation. Front Endocrinol (Lausanne) 2010;1:5.
31. Chen J, Xu H, Shen Q, Guo W, Sun L. Efect of postnatal high-protein diet on kidney function of rats exposed to intrauterine protein restriction. Pediatr Res 2010;68:100-104.
32. Fanos V, Puddu M, Reali A, Atzei A, Zafanello M. Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: a review. Early Hum Dev 2010;86 Suppl 1:37-42.
33. Cottrell EC, Seckl Jr. Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 2009;3:19.
34. Seckl Jr. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004;151 Suppl 3:U49-U62.
35. Nezar MA, el-Baky AM, Soliman OA, Abdel-Hady HA, Hammad AM, Al-Haggar MS. Endothelin-1 and leptin as markers of intrauterine growth restriction. Indian J Pediatr 2009;76:485-488.
36. Florio P, Marinoni E, Di Iorio R, Bashir M, Ciotti S, Sacchi R, Bruschettini M, et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics 2006;118:e747-e754.
37. Malamitsi-Puchner A, Briana DD, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007;119:e1314-e1318.
38. Randhawa R, Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab 2005;86:84-90.
39. Holness MJ, Sugden MC. Epigenetic regulation of metabolism in children born small for gestational age. Curr Opin Clin Nutr Metab Care 2006;9:482-488.
40. Coen M, Holmes E, Lindon JC, Nicholson JK. NMR-based metabolic profling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008;21:9-27.
41. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153-161.
42. Nissen PM, Nebel C, Oksbjerg N, Bertram HC. Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. J Biomed Biotechnol 2011;2011:378268.
43. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, Hansen BC, et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1990;323:373-378.
44. Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 1993;90:9988-9992.
45. Dessì A, Atzori L, Noto A, Visser GH, Gazzolo D, Zanardo V, Barberini L, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011;24 Suppl 2:35-39.
46. Sugita O, Uchiyama K, Yamada T, Sato T, Okada M, Takeuchi K. Reference values of serum and urine creatinine, and of creatinine clearance by a new enzymatic method. Ann Clin Biochem 1992;29 (Pt 5):523-528.
47. Lam YY, Hatzinikolas G, Weir JM, Janovská A, McAinch AJ, Game P, Meikle PJ, Wittert GA. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the efects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta 2011;1811:468-475.
48. Muhlhausler BS, Dufeld JA, Ozanne SE, Pilgrim C, Turner N, Morrison JL, McMillen IC. The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle. J Physiol (Lond) 2009;587:4199-4211.
49. Favretto D, Cosmi E, Ragazzi E, Visentin S, Tucci M, Fais P, Cecchetto G, et al. Cord blood metabolomic profling in intrauterine growth restriction. Anal Bioanal Chem 2012;402:1109-1121.
50. Alexandre-Gouabau MC, Courant F, Le Gall G, Moyon T, Darmaun D, Parnet P, Coupé B, Antignac J P. Ofspring metabolomic response to maternal protein restriction in a rat model of intrauterine growth restriction (IUGR). J Proteome Res 2011;10:3292-3302.
51. Barker DJ, Osmond C, Simmonds SJ, Wield GA. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 1993;306:422-426.
52. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993;36:225-228.
53. Osmond C, Barker DJ, Winter PD, Fall CH, Simmonds SJ. Early growth and death from cardiovascular disease in women. BMJ 1993;307:1519-1524.
54. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH. Birth weight and non-insulin dependent diabetes: thrify genotype, thrify phenotype, or surviving small baby genotype? BMJ 1994;308:942-945.
55. Martyn CN, Barker DJ, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood pressure, and arterial compliance. Br Heart J 1995;73:116-121.
56. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996;94:3246-3250.
57. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 1996;348:1478-1480.
58. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996;312:406-410.
59. Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJ. Fetal growth and coronary heart disease in south India. Lancet 1996;348:1269-1273.
60. Rich-Edwards J W, Stampfer MJ, Manson JE, Rosner B, Hankinson SE, Colditz GA, Willett WC, Hennekens CH. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 1997;315:396-400.
61. Leon DA, Lithell HO, Vâgerö D, Koupilová I, Mohsen R, Berglund L, Lithell UB, McKeigue PM. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 1998;317:241-245.
62. Levitt NS, Lambert EV, Woods D, Hales CN, Andrew R, Seckl Jr. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south African adults: early programming of cortisol axis. J Clin Endocrinol Metab 2000;85:4611-4618.
63. Xiao X, Zhang ZX, Li WH, Feng K, Sun Q, Cohen HJ, Xu T, et al. Low birth weight is associated with components of the metabolic syndrome. Metab Clin Exp 2010;59:1282-1286.
64. Meas T, Deghmoun S, Alberti C, Carreira E, Armoogum P, Chevenne D, Lévy-Marchal C. Independent efects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia 2010;53:907-913.